12:00 AM
 | 
Jul 20, 2009
 |  BC Week In Review  |  Company News  |  Deals

Abbott, GlaxoSmithKline deal

Abbott partnered with GlaxoSmithKline to co-develop and commercialize a PCR-based companion diagnostic for GSK's MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapy) for non-small cell lung...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >